부산대학교 도서관

Hollmen M; Bromilow T; Smith AB; Mealing S; Lewis D; Galvin L; Jones S; Pacheco L; Soulard S; Froidure A

Patient Preference and Adherence, Vol Volume 17, Pp 1621-1639 (2023)

Hollmen M; Wijsenbeek M; Bromilow T; Smith AB; Mealing S; Lewis D; Galvin L; Jones S; Asijee G; Soulard S; Froidure A

Patient Preference and Adherence, Vol Volume 17, Pp 1895-1906 (2023)

Rannikko JH; MediCity Research Laboratory and InFLAMES Flagship, University of Turku, Turku, Finland.; Turku Doctoral Program of Molecular Medicine, University of Turku, Turku, Finland.; Hollmén M; MediCity Research Laboratory and InFLAMES Flagship, University of Turku, Turku, Finland. maijal@utu.fi.; Faron Pharmaceuticals Ltd, Turku, Finland. maijal@utu.fi.

Publisher: Nature Publishing Group on behalf of Cancer Research UK Country of Publication: England NLM ID: 0370635 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-1827 (Electronic) Linking ISSN: 00070920 NLM ISO Abbreviation: Br J Cancer Subsets: MEDLINE

Linna-Kuosmanen S; Computer Science and Artificial Intelligence Laboratory, Massachusetts Institute of Technology, Cambridge, MA 02139, USA; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA; A. I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, 70211 Kuopio, Finland. Electronic address: suvi.linna-kuosmanen@uef.fi.; Schmauch E; Computer Science and Artificial Intelligence Laboratory, Massachusetts Institute of Technology, Cambridge, MA 02139, USA; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA; A. I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, 70211 Kuopio, Finland.; Galani K; Computer Science and Artificial Intelligence Laboratory, Massachusetts Institute of Technology, Cambridge, MA 02139, USA; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA.; Ojanen J; Computer Science and Artificial Intelligence Laboratory, Massachusetts Institute of Technology, Cambridge, MA 02139, USA; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA; A. I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, 70211 Kuopio, Finland.; Boix CA; Computer Science and Artificial Intelligence Laboratory, Massachusetts Institute of Technology, Cambridge, MA 02139, USA; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA.; Örd T; A. I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, 70211 Kuopio, Finland.; Toropainen A; A. I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, 70211 Kuopio, Finland.; Singha PK; A. I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, 70211 Kuopio, Finland.; Moreau PR; A. I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, 70211 Kuopio, Finland.; Harju K; A. I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, 70211 Kuopio, Finland.; Blazeski A; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA; Center for Excellence in Vascular Biology, Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, USA.; Segerstolpe Å; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA.; Lahtinen V; Heart Center, Turku University Hospital, 20521 Turku, Finland; MediCity Research Laboratories and InFLAMES Flagship, University of Turku, 20500 Turku, Finland.; Hou L; Computer Science and Artificial Intelligence Laboratory, Massachusetts Institute of Technology, Cambridge, MA 02139, USA; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA.; Kang K; Computer Science and Artificial Intelligence Laboratory, Massachusetts Institute of Technology, Cambridge, MA 02139, USA; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA.; Meibalan E; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA; Center for Excellence in Vascular Biology, Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, USA.; Agudelo LZ; Computer Science and Artificial Intelligence Laboratory, Massachusetts Institute of Technology, Cambridge, MA 02139, USA; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA.; Kokki H; School of Medicine, University of Eastern Finland, 70211 Kuopio, Finland.; Halonen J; School of Medicine, University of Eastern Finland, 70211 Kuopio, Finland; Heart Center, Kuopio University Hospital, 70200 Kuopio, Finland.; Jalkanen J; MediCity Research Laboratories and InFLAMES Flagship, University of Turku, 20500 Turku, Finland.; Gunn J; Heart Center, Turku University Hospital, 20521 Turku, Finland; Department of Medicine, University of Turku, 20500 Turku, Finland.; MacRae CA; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA; Department of Medicine, Harvard Medical School, Boston, MA 02115, USA; Cardiovascular Medicine and Network Medicine Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA; Harvard Stem Cell Institute, Cambridge, MA 02138, USA.; Hollmén M; MediCity Research Laboratories and InFLAMES Flagship, University of Turku, 20500 Turku, Finland.; Hartikainen JEK; School of Medicine, University of Eastern Finland, 70211 Kuopio, Finland; Heart Center, Kuopio University Hospital, 70200 Kuopio, Finland.; Kaikkonen MU; A. I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, 70211 Kuopio, Finland.; García-Cardeña G; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA; Center for Excellence in Vascular Biology, Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, USA; Harvard Stem Cell Institute, Cambridge, MA 02138, USA.; Tavi P; A. I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, 70211 Kuopio, Finland.; Kiviniemi T; Heart Center, Turku University Hospital, 20521 Turku, Finland; Department of Medicine, University of Turku, 20500 Turku, Finland; Cardiovascular Medicine and Network Medicine Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.; Kellis M; Computer Science and Artificial Intelligence Laboratory, Massachusetts Institute of Technology, Cambridge, MA 02139, USA; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA. Electronic address: manoli@mit.edu.

Publisher: Cell Press Country of Publication: United States NLM ID: 101766894 Publication Model: Print Cited Medium: Internet ISSN: 2666-3791 (Electronic) Linking ISSN: 26663791 NLM ISO Abbreviation: Cell Rep Med Subsets: MEDLINE

Turpin R; Translational Cancer Medicine, University of Helsinki, Helsinki, Finland.; Liu R; Translational Cancer Medicine, University of Helsinki, Helsinki, Finland.; Munne PM; Translational Cancer Medicine, University of Helsinki, Helsinki, Finland.; Peura A; Translational Cancer Medicine, University of Helsinki, Helsinki, Finland.; Rannikko JH; University of Turku, Turku, Finland.; Philips G; KU Leuven, Leuven, Belgium.; Boeckx B; Department of Human Genetics, KU Leuven, Leuven, Belgium.; Salmelin N; Translational Cancer Medicine, University of Helsinki, Helsinki, Finland.; Hurskainen E; Translational Cancer Medicine, University of Helsinki, Helsinki, Finland.; Suleymanova I; Translational Cancer Medicine, University of Helsinki, Helsinki, Finland.; Aung J; University of Helsinki Faculty of Medicine, Helsinki, Finland.; Vuorinen EM; SCellex, Helsinki, Finland.; Lehtinen L; SCellex, Helsinki, Finland.; Mutka M; Department of Pathology, Helsinki University Central Hospital, Helsinki, Finland.; Kovanen PE; Department of Pathology, HUSLAB, Helsinki University Central Hospital, Helsinki, Finland.; Niinikoski L; Breast Surgery Unit, Helsinki University Central Hospital Comprehensive Cancer Center, Helsinki, Finland.; Meretoja TJ; Breast Surgery Unit, Helsinki University Central Hospital Comprehensive Cancer Center, Helsinki, Finland.; Mattson J; Department of oncology, Helsinki University Central Hospital, Helsinki, Finland.; Mustjoki S; TRIMM, Translational Immunology Research Program, University of Helsinki, Helsinki, Finland.; University of Helsinki Helsinki Institute of Life Sciences, Helsinki, Finland.; Saavalainen P; SCellex, Helsinki, Finland.; Goga A; Department of Cell & Tissue Biology, UCSF, San Francisco, California, USA.; Lambrechts D; VIB-KU Leuven Center for Cancer Biology, Leuven, Belgium.; Pouwels J; Translational Cancer Medicine, University of Helsinki, Helsinki, Finland.; Hollmén M; University of Turku, Turku, Finland.; Klefström J; Translational Cancer Medicine, University of Helsinki, Helsinki, Finland juha.klefstrom@helsinki.fi.; Finnish Cancer Institute, Helsinki, Finland.

Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101620585 Publication Model: Electronic Cited Medium: Internet ISSN: 2051-1426 (Electronic) Linking ISSN: 20511426 NLM ISO Abbreviation: J Immunother Cancer Subsets: MEDLINE

Viikinkoski E; Heart Center, Turku University Hospital and University of Turku, Turku, Finland.; Aittokallio J; Heart Center, Turku University Hospital and University of Turku, Turku, Finland.; Lehto J; Heart Center, Turku University Hospital and University of Turku, Turku, Finland.; Ollila H; Turku Clinical Research Center, Turku University Hospital, Turku, Finland.; Relander A; Heart Center, Turku University Hospital and University of Turku, Turku, Finland.; Vasankari T; Heart Center, Turku University Hospital and University of Turku, Turku, Finland.; Jalkanen J; MediCity Research Laboratory, Department of Microbiology and Immunology, InFLAMES Flagship, University of Turku, Turku, Finland.; Gunn J; Heart Center, Turku University Hospital and University of Turku, Turku, Finland.; Jalkanen S; MediCity Research Laboratory, Department of Microbiology and Immunology, InFLAMES Flagship, University of Turku, Turku, Finland.; Airaksinen J; Heart Center, Turku University Hospital and University of Turku, Turku, Finland.; Hollmén M; MediCity Research Laboratory, Department of Microbiology and Immunology, InFLAMES Flagship, University of Turku, Turku, Finland.; Kiviniemi TO; Heart Center, Turku University Hospital and University of Turku, Turku, Finland. Electronic address: tuoski@utu.fi.

Publisher: W.B. Saunders Country of Publication: United States NLM ID: 9110208 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-8422 (Electronic) Linking ISSN: 10530770 NLM ISO Abbreviation: J Cardiothorac Vasc Anesth Subsets: MEDLINE

Rannikko JH; MediCity Research Laboratory and InFLAMES Flagship, University of Turku, Turku, Finland.; Bono P; Terveystalo, Helsinki, Finland.; Hynninen J; Department of Obstetrics and Gynecology, University of Turku and Turku University Hospital, Turku, Finland.; Hollmén M; MediCity Research Laboratory and InFLAMES Flagship, University of Turku, Turku, Finland.

Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 101614637 Publication Model: Print Cited Medium: Internet ISSN: 2326-6074 (Electronic) Linking ISSN: 23266066 NLM ISO Abbreviation: Cancer Immunol Res Subsets: MEDLINE

Rannikko JH; MediCity Research Laboratory and InFLAMES Flagship, University of Turku, Turku, Finland; Turku Doctoral Program of Molecular Medicine, University of Turku, Turku, Finland.; Verlingue L; Institut Gustave Roussy, Paris and Centre Leon Berard in Lyon, Lyon, France.; de Miguel M; START-CIOCC HM Sanchinarro, Madrid, Spain.; Pasanen A; Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland.; Robbrecht D; Erasmus Medical Center/Cancer Institute, Rotterdam, the Netherlands.; Skytta T; Tampere University Hospital, Tampere, Finland.; Iivanainen S; Oulu University Hospital, University of Oulu, Oulu, Finland.; Shetty S; University of Birmingham/University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.; Ma YT; University of Birmingham/University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.; Graham DM; The Christie NHS Foundation Trust, Manchester, UK.; Arora SP; Mays Cancer Center, UT Health San Antonio, San Antonio, TX, USA.; Jaakkola P; Department of Oncology, Turku University Hospital and University of Turku, Turku, Finland.; Yap C; Clinical Trials and Statistics Unit, The Institute of Cancer Research, London, UK.; Xiang Y; INDIVIDRUG Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland.; Mandelin J; Faron Pharmaceuticals Ltd, Turku, Finland.; Karvonen MK; Faron Pharmaceuticals Ltd, Turku, Finland.; Jalkanen J; Faron Pharmaceuticals Ltd, Turku, Finland.; Karaman S; INDIVIDRUG Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland; Wihuri Research Institute, Helsinki, Finland.; Koivunen JP; Oulu University Hospital, University of Oulu, Oulu, Finland; Faron Pharmaceuticals Ltd, Turku, Finland.; Minchom A; Drug Development Unit, Royal Marsden Hospital/Institute of Cancer Research, Sutton, UK.; Hollmén M; MediCity Research Laboratory and InFLAMES Flagship, University of Turku, Turku, Finland; Faron Pharmaceuticals Ltd, Turku, Finland. Electronic address: maijal@utu.fi.; Bono P; Terveystalo Finland and University of Helsinki, Helsinki, Finland. Electronic address: petri.bono@terveystalo.com.

Publisher: Cell Press Country of Publication: United States NLM ID: 101766894 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2666-3791 (Electronic) Linking ISSN: 26663791 NLM ISO Abbreviation: Cell Rep Med Subsets: MEDLINE

Dufva O; Hematology Research Unit Helsinki, Helsinki University Hospital Comprehensive Cancer Center, 00290 Helsinki, Finland; Translational Immunology Research Program and Department of Clinical Chemistry and Hematology, University of Helsinki, 00014 Helsinki, Finland; iCAN Digital Precision Cancer Medicine Flagship, 00290 Helsinki, Finland.; Gandolfi S; Hematology Research Unit Helsinki, Helsinki University Hospital Comprehensive Cancer Center, 00290 Helsinki, Finland; Translational Immunology Research Program and Department of Clinical Chemistry and Hematology, University of Helsinki, 00014 Helsinki, Finland; iCAN Digital Precision Cancer Medicine Flagship, 00290 Helsinki, Finland; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02215, USA; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA.; Huuhtanen J; Hematology Research Unit Helsinki, Helsinki University Hospital Comprehensive Cancer Center, 00290 Helsinki, Finland; Translational Immunology Research Program and Department of Clinical Chemistry and Hematology, University of Helsinki, 00014 Helsinki, Finland; iCAN Digital Precision Cancer Medicine Flagship, 00290 Helsinki, Finland; Department of Computer Science, Aalto University, 02150 Espoo, Finland.; Dashevsky O; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02215, USA; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA; Department of Medicine, Harvard Medical School, Boston, MA 02215, USA; Ludwig Center, Harvard Medical School, Boston, MA 02215, USA.; Duàn H; Hematology Research Unit Helsinki, Helsinki University Hospital Comprehensive Cancer Center, 00290 Helsinki, Finland; Translational Immunology Research Program and Department of Clinical Chemistry and Hematology, University of Helsinki, 00014 Helsinki, Finland; iCAN Digital Precision Cancer Medicine Flagship, 00290 Helsinki, Finland.; Saeed K; Hematology Research Unit Helsinki, Helsinki University Hospital Comprehensive Cancer Center, 00290 Helsinki, Finland; Translational Immunology Research Program and Department of Clinical Chemistry and Hematology, University of Helsinki, 00014 Helsinki, Finland.; Klievink J; Hematology Research Unit Helsinki, Helsinki University Hospital Comprehensive Cancer Center, 00290 Helsinki, Finland; Translational Immunology Research Program and Department of Clinical Chemistry and Hematology, University of Helsinki, 00014 Helsinki, Finland; iCAN Digital Precision Cancer Medicine Flagship, 00290 Helsinki, Finland.; Nygren P; Hematology Research Unit Helsinki, Helsinki University Hospital Comprehensive Cancer Center, 00290 Helsinki, Finland; Translational Immunology Research Program and Department of Clinical Chemistry and Hematology, University of Helsinki, 00014 Helsinki, Finland; iCAN Digital Precision Cancer Medicine Flagship, 00290 Helsinki, Finland.; Bouhlal J; Hematology Research Unit Helsinki, Helsinki University Hospital Comprehensive Cancer Center, 00290 Helsinki, Finland; Translational Immunology Research Program and Department of Clinical Chemistry and Hematology, University of Helsinki, 00014 Helsinki, Finland; iCAN Digital Precision Cancer Medicine Flagship, 00290 Helsinki, Finland.; Lahtela J; Institute for Molecular Medicine Finland (FIMM), HiLIFE, University of Helsinki, 00014 Helsinki, Finland.; Näätänen A; Institute for Molecular Medicine Finland (FIMM), HiLIFE, University of Helsinki, 00014 Helsinki, Finland.; Ghimire BR; Institute for Molecular Medicine Finland (FIMM), HiLIFE, University of Helsinki, 00014 Helsinki, Finland.; Hannunen T; Institute for Molecular Medicine Finland (FIMM), HiLIFE, University of Helsinki, 00014 Helsinki, Finland.; Ellonen P; Institute for Molecular Medicine Finland (FIMM), HiLIFE, University of Helsinki, 00014 Helsinki, Finland.; Lähteenmäki H; Hematology Research Unit Helsinki, Helsinki University Hospital Comprehensive Cancer Center, 00290 Helsinki, Finland; Translational Immunology Research Program and Department of Clinical Chemistry and Hematology, University of Helsinki, 00014 Helsinki, Finland.; Rumm P; Hematology Research Unit Helsinki, Helsinki University Hospital Comprehensive Cancer Center, 00290 Helsinki, Finland; Translational Immunology Research Program and Department of Clinical Chemistry and Hematology, University of Helsinki, 00014 Helsinki, Finland.; Theodoropoulos J; Hematology Research Unit Helsinki, Helsinki University Hospital Comprehensive Cancer Center, 00290 Helsinki, Finland; Translational Immunology Research Program and Department of Clinical Chemistry and Hematology, University of Helsinki, 00014 Helsinki, Finland.; Laajala E; Hematology Research Unit Helsinki, Helsinki University Hospital Comprehensive Cancer Center, 00290 Helsinki, Finland; Translational Immunology Research Program and Department of Clinical Chemistry and Hematology, University of Helsinki, 00014 Helsinki, Finland; iCAN Digital Precision Cancer Medicine Flagship, 00290 Helsinki, Finland.; Härkönen J; Faculty of Health Sciences, A.I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, 70211 Kuopio, Finland.; Pölönen P; Department of Pathology, St. Jude Children's Research Hospital, Memphis, TN 38105, USA.; Heinäniemi M; Faculty of Health Sciences, A.I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, 70211 Kuopio, Finland.; Hollmén M; Medicity Research Laboratory, University of Turku, 20014 Turku, Finland.; Yamano S; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02215, USA; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA; Department of Medicine, Harvard Medical School, Boston, MA 02215, USA; Ludwig Center, Harvard Medical School, Boston, MA 02215, USA.; Shirasaki R; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02215, USA; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA; Department of Medicine, Harvard Medical School, Boston, MA 02215, USA; Ludwig Center, Harvard Medical School, Boston, MA 02215, USA.; Barbie DA; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02215, USA; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA; Department of Medicine, Harvard Medical School, Boston, MA 02215, USA; Ludwig Center, Harvard Medical School, Boston, MA 02215, USA.; Roth JA; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA.; Romee R; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02215, USA; Department of Medicine, Harvard Medical School, Boston, MA 02215, USA; Ludwig Center, Harvard Medical School, Boston, MA 02215, USA.; Sheffer M; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02215, USA; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA; Department of Medicine, Harvard Medical School, Boston, MA 02215, USA; Ludwig Center, Harvard Medical School, Boston, MA 02215, USA.; Lähdesmäki H; Department of Computer Science, Aalto University, 02150 Espoo, Finland.; Lee DA; Hematology/Oncology/BMT, Center for Childhood Cancer and Blood Diseases, Nationwide Children's Hospital, Columbus, OH 43205, USA.; De Matos Simoes R; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02215, USA; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA; Department of Medicine, Harvard Medical School, Boston, MA 02215, USA; Ludwig Center, Harvard Medical School, Boston, MA 02215, USA.; Kankainen M; Hematology Research Unit Helsinki, Helsinki University Hospital Comprehensive Cancer Center, 00290 Helsinki, Finland; Translational Immunology Research Program and Department of Clinical Chemistry and Hematology, University of Helsinki, 00014 Helsinki, Finland; iCAN Digital Precision Cancer Medicine Flagship, 00290 Helsinki, Finland; Laboratory of Genetics, HUS Diagnostic Center, Hospital District of Helsinki and Uusima (HUS), 00290 Helsinki, Finland.; Mitsiades CS; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02215, USA; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA; Department of Medicine, Harvard Medical School, Boston, MA 02215, USA; Ludwig Center, Harvard Medical School, Boston, MA 02215, USA. Electronic address: constantine_mitsiades@dfci.harvard.edu.; Mustjoki S; Hematology Research Unit Helsinki, Helsinki University Hospital Comprehensive Cancer Center, 00290 Helsinki, Finland; Translational Immunology Research Program and Department of Clinical Chemistry and Hematology, University of Helsinki, 00014 Helsinki, Finland; iCAN Digital Precision Cancer Medicine Flagship, 00290 Helsinki, Finland. Electronic address: satu.mustjoki@helsinki.fi.

Publisher: Cell Press Country of Publication: United States NLM ID: 9432918 Publication Model: Print Cited Medium: Internet ISSN: 1097-4180 (Electronic) Linking ISSN: 10747613 NLM ISO Abbreviation: Immunity Subsets: MEDLINE

Prince S; MediCity Research Laboratory and InFLAMES Flagship, University of Turku, Turku, Finland.; Hollmén M; MediCity Research Laboratory and InFLAMES Flagship, University of Turku, Turku, Finland. Electronic address: maijal@utu.fi.

Publisher: Cell Press Country of Publication: United States NLM ID: 9432918 Publication Model: Print Cited Medium: Internet ISSN: 1097-4180 (Electronic) Linking ISSN: 10747613 NLM ISO Abbreviation: Immunity Subsets: MEDLINE